This HTML5 document contains 36 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n11http://linked.opendata.cz/resource/drugbank/drug/DB02581/identifier/pubchem-compound/
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n12http://linked.opendata.cz/resource/drugbank/drug/DB02581/identifier/pubchem-substance/
n8http://linked.opendata.cz/resource/drugbank/drug/DB02581/identifier/drugbank/
n13http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n10http://linked.opendata.cz/resource/drugbank/drug/DB02581/identifier/chemspider/
n6http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#
n9http://linked.opendata.cz/resource/drugbank/drug/DB02581/identifier/pdb/

Statements

Subject Item
n2:DB02581
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n6:DB02581 n13:DB02581
dcterms:title
5-[2,3-Dichloro-4-(5-{1-[2-(2-Guanidino-4-Methyl-Pentanoylamino)-Acetyl]-Piperidin-4-Yl}-1-Methyl-1h-Pyrazol-3-Yl)-Phenoxymethyl]-Furan-2-Carboxylic Acid
adms:identifier
n8:DB02581 n9:FRH n10:19562772 n11:5288251 n12:46505835
n3:IUPAC-Name
n4:271B44B9-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B44BF-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B44BE-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B44BB-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B44BC-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B44BD-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B44B7-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B44B8-363D-11E5-9242-09173F13E4C5 n4:271B44B5-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B44B6-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B44C5-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B44C6-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B44C0-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B44C1-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B44C3-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B44C2-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B44C4-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n4:271B44CB-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B44CD-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B44CE-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B44CA-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B44C9-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B44CC-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B44BA-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B44C7-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B44C8-363D-11E5-9242-09173F13E4C5